WO2013006854A9 - Compositions and methods for treating enterobacteriaceae - Google Patents

Compositions and methods for treating enterobacteriaceae Download PDF

Info

Publication number
WO2013006854A9
WO2013006854A9 PCT/US2012/045943 US2012045943W WO2013006854A9 WO 2013006854 A9 WO2013006854 A9 WO 2013006854A9 US 2012045943 W US2012045943 W US 2012045943W WO 2013006854 A9 WO2013006854 A9 WO 2013006854A9
Authority
WO
WIPO (PCT)
Prior art keywords
enterobacteriaceae
compositions
treating
methods
treating enterobacteriaceae
Prior art date
Application number
PCT/US2012/045943
Other languages
French (fr)
Other versions
WO2013006854A2 (en
Inventor
Stanley M SPINOLA
Original Assignee
Indiana University Research And Technology Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indiana University Research And Technology Corporation filed Critical Indiana University Research And Technology Corporation
Publication of WO2013006854A2 publication Critical patent/WO2013006854A2/en
Publication of WO2013006854A9 publication Critical patent/WO2013006854A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PCT/US2012/045943 2011-07-07 2012-07-09 Compositions and methods for treating enterobacteriaceae WO2013006854A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161505303P 2011-07-07 2011-07-07
US61/505,303 2011-07-07

Publications (2)

Publication Number Publication Date
WO2013006854A2 WO2013006854A2 (en) 2013-01-10
WO2013006854A9 true WO2013006854A9 (en) 2013-04-11

Family

ID=47437736

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/045943 WO2013006854A2 (en) 2011-07-07 2012-07-09 Compositions and methods for treating enterobacteriaceae

Country Status (1)

Country Link
WO (1) WO2013006854A2 (en)

Also Published As

Publication number Publication date
WO2013006854A2 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
EP2684167A4 (en) Compositions and methods useful for treating diseases
IL227429A0 (en) Compositions and methods for treating cancer
GB2494845B (en) Compositions and methods for treating automotive surfaces
EP2755482A4 (en) Compositions and methods for treating cancer
EP2663635A4 (en) Microbial compositions and methods
EP2771030A4 (en) Compositions and methods for treatment of proteinopathies
HK1190936A1 (en) Methods and compositions for treating metabolic syndrome
GB201408236D0 (en) Composition and method
GB201122195D0 (en) Composition and method
ZA201404187B (en) Compositions and methods for treating dental conditions
ZA201307187B (en) Synergistic compositions and methods
HK1201469A1 (en) Compositions and methods for hemostasis
EP2830654B8 (en) Methods and compositions for treating inflammation
IL232648A0 (en) Compositions and methods for treating glioma
IL229231A0 (en) Compositions and methods for treating cancer
PL2731963T3 (en) Compositions and methods for immunomodulation
ZA201308892B (en) Compositions and methods
EP2723346A4 (en) Compositions and methods useful for treating pediculosis
EP2766357A4 (en) Meso-biliverdin compositions and methods
GB201106433D0 (en) Composition and method
IL231798A0 (en) Method and composition
WO2013003465A9 (en) Methods and compositions for treating skin
ZA201308683B (en) Methods and compositions suitable for preventing and treating hyperleptinemia
EP2718427A4 (en) Compositions and methods for glioblastoma treatment
WO2013006854A9 (en) Compositions and methods for treating enterobacteriaceae

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12808113

Country of ref document: EP

Kind code of ref document: A2